Amarin Corp Plc (AMRN)

[CaptBeer]

$AMRN New data from the REDUCE-IT study to be published in JACC next week, shows a 40% RRR in sudden cardiac death and a WHOPPING 56% RRR in cardiac arrest in patients who have had a prior MI while on Icosapent Ethyl (VASCEPA®) vs. a placebo!
In addition to these significant reductions, there were significant reductions in the Primary Composite Endpoints (26% RRR) and Secondary Composite Endpoints (29% RRR).

https://www.sciencedirect.com/science/article/pii/S0735109722005538